The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020

Detalles Bibliográficos
Autores principales: Oliver, Sara E., Gargano, Julia W., Marin, Mona, Wallace, Megan, Curran, Kathryn G., Chamberland, Mary, McClung, Nancy, Campos-Outcalt, Doug, Morgan, Rebecca L., Mbaeyi, Sarah, Romero, José R., Talbot, H. Keipp, Lee, Grace M., Bell, Beth P., Dooling, Kathleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745957/
https://www.ncbi.nlm.nih.gov/pubmed/33332292
http://dx.doi.org/10.15585/mmwr.mm6950e2
_version_ 1783624694250864640
author Oliver, Sara E.
Gargano, Julia W.
Marin, Mona
Wallace, Megan
Curran, Kathryn G.
Chamberland, Mary
McClung, Nancy
Campos-Outcalt, Doug
Morgan, Rebecca L.
Mbaeyi, Sarah
Romero, José R.
Talbot, H. Keipp
Lee, Grace M.
Bell, Beth P.
Dooling, Kathleen
author_facet Oliver, Sara E.
Gargano, Julia W.
Marin, Mona
Wallace, Megan
Curran, Kathryn G.
Chamberland, Mary
McClung, Nancy
Campos-Outcalt, Doug
Morgan, Rebecca L.
Mbaeyi, Sarah
Romero, José R.
Talbot, H. Keipp
Lee, Grace M.
Bell, Beth P.
Dooling, Kathleen
author_sort Oliver, Sara E.
collection PubMed
description
format Online
Article
Text
id pubmed-7745957
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-77459572021-01-01 The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020 Oliver, Sara E. Gargano, Julia W. Marin, Mona Wallace, Megan Curran, Kathryn G. Chamberland, Mary McClung, Nancy Campos-Outcalt, Doug Morgan, Rebecca L. Mbaeyi, Sarah Romero, José R. Talbot, H. Keipp Lee, Grace M. Bell, Beth P. Dooling, Kathleen MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2020-12-18 /pmc/articles/PMC7745957/ /pubmed/33332292 http://dx.doi.org/10.15585/mmwr.mm6950e2 Text en https://creativecommons.org/licenses/by/3.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
spellingShingle Full Report
Oliver, Sara E.
Gargano, Julia W.
Marin, Mona
Wallace, Megan
Curran, Kathryn G.
Chamberland, Mary
McClung, Nancy
Campos-Outcalt, Doug
Morgan, Rebecca L.
Mbaeyi, Sarah
Romero, José R.
Talbot, H. Keipp
Lee, Grace M.
Bell, Beth P.
Dooling, Kathleen
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
title The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
title_full The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
title_fullStr The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
title_full_unstemmed The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
title_short The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
title_sort advisory committee on immunization practices’ interim recommendation for use of pfizer-biontech covid-19 vaccine — united states, december 2020
topic Full Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745957/
https://www.ncbi.nlm.nih.gov/pubmed/33332292
http://dx.doi.org/10.15585/mmwr.mm6950e2
work_keys_str_mv AT oliversarae theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT garganojuliaw theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT marinmona theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT wallacemegan theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT currankathryng theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT chamberlandmary theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT mcclungnancy theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT camposoutcaltdoug theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT morganrebeccal theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT mbaeyisarah theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT romerojoser theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT talbothkeipp theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT leegracem theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT bellbethp theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT doolingkathleen theadvisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT oliversarae advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT garganojuliaw advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT marinmona advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT wallacemegan advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT currankathryng advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT chamberlandmary advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT mcclungnancy advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT camposoutcaltdoug advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT morganrebeccal advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT mbaeyisarah advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT romerojoser advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT talbothkeipp advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT leegracem advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT bellbethp advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020
AT doolingkathleen advisorycommitteeonimmunizationpracticesinterimrecommendationforuseofpfizerbiontechcovid19vaccineunitedstatesdecember2020

Ejemplares similares